FERRUCCIO FAZIO

 

Elenco pubblicazioni

 

 

 

Anno 2013

  1. Belloli S, Brioschi A, Politi LS, Ronchetti F, Calderoni S, Raccagni I, Pagani A, Monterisi C, Zenga F, Zara G, Fazio F, Mauro A, Moresco RM. Characterization of biological features of a rat F98 GBM model: a PET-MRI study with [18F]FAZA and [18F]FDG. Nucl Med Biol, 2013; 40 (6): 831-840.

  2. Beltrami E, Valtorta S, Moresco R, Marcu R, Belloli S, Fassina A, Fazio F, Pelicci P, Giorgio M. The p53-p66Shc apoptotic pathway is dispensable for tumor suppression whereas the p66Shc-generated oxidative stress initiates tumorigenesis. Curr Pharm Des, 2013; 19 (15): 2708-2714.

  3. Russo V, Pilla L, Lunghi F, Crocchiolo R, Greco R, Ciceri F, Maggioni D, Fontana R, Mukenge S, Rivoltini L, Rigamonti G, Mercuri SR, Nicoletti R, Maschio AD, Gianolli L, Fazio F, Marchianò A, Florio AD, Maio M, Salomoni M, Gallo-Stampino C, Fiacco MD, Lambiase A, Coulie PG, Patuzzo R, Parmiani G, Traversari C, Bordignon C, Santinami M, Bregni M.Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes. Int J Cancer, 2013; 132 (11): 2557-2566.

  4. Valtorta S, Belloli S, Sanvito F, Masiello V, Di Grigoli G, Monterisi C, Fazio F, Picchio M and Moresco RM. Comparison of [18F]FAZA and [64Cu]ATSM in preclinical models of Cancer. J Nucl Med, 2013; 54 (7): 1106-1112.



Anno 2012

  1. Russo V, Pilla L, Lunghi F, Crocchiolo R, Greco R, Ciceri F, Maggioni D, Fontana R, Mukenge S, Rivoltini L, Rigamonti G, Mercuri SR, Nicoletti R, Maschio AD, Gianolli L, Fazio F, Marchianò A, Florio AD, Maio M, Salomoni M, Gallo-Stampino C, Fiacco MD, Lambiase A, Coulie PG, Patuzzo R, Parmiani G, Traversari C, Bordignon C, Santinami M, Bregni M.Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes. Int J Cancer. (Published on.line: November 13, 2012).

  2. Zambelli V*, Di Grigoli G*, Scanziani M, Valtorta S, Amigoni M, Belloli S, Messa C, Pesenti A, Fazio F, Bellani G, Moresco RM. Time course of metabolic activity and cellular infiltration in a murine model of acid-induced lung injury. Intensive Care Medicine, 2012; 38 (4): 694-701. (* Equal contribution).



Anno 2011

  1. Belloni E, Canevari C, Panizza P, Marassi A, Rodighiero M, Tacchini S, Zuber V, Sassi I, Gianolli L, Fazio F, Del Maschio A. Nonpalpable breast lesions: preoperative radiological guidance in radioguided occult lesion localisation (ROLL). Radiol Med, 2011; 116 (4): 564-574.

  2. Cottone L, Valtorta S, Capobianco A, Belloli S, Rovere-Querini P, Fazio F, Manfredi AA, Moresco RM. Evaluation of the role of tumor-associated macrophages in an experimental model of peritoneal carcinomatosis using [18F]-FDG-PET. J Nucl Med, 2011; 52 (11): 1770-1777.

  3. Giuliani G, Cappelli A, Matarrese M, Masiello V, Turolla EA, Monterisi C, Fazio F, Anzini M, Riitano D, Finetti F, Morbidelli L, Ziche M, Giorgi G, Vomero S. Non-Peptide NK1 Receptor Ligands Based on the 4-Phenylpiridine Moiety. Bioorg Med Chem, 2011; 19 (7): 2242-2251.

 

Anno 2010

  1. Dell’Acqua F, Scifo P, Rizzo G, Catani M, Simmons A, Scotti G, Fazio F. A Modified Damped Richardson Lucy Algorithm to Reduce Isotropic Background Effects in Spherical Deconvolution. NeuroImage, 2010; 49: 1446-1458.

  2. Giovacchini G, Picchio M, Coradeschi E, Bettinardi V, Gianolli L, Scattoni V, Cozzarini C, Di Muzio N, Rigatti P, Fazio F, Messa C. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging, 2010; 37 (2): 301-309.

  3. Ippolito D, Bonaffini PA, Ratti L, Antolini L, Corso R, Fazio F, Sironi S. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor. World J Gastroenterol, 2010; 16 (47): 5993-6000.

  4. Ippolito D, Sironi S, Pozzi M, Antolini L, Invernizzi F, Ratti L, Leone EB, Fazio F. Perfusion CT in cirrhotic patients with early stage hepatocellular carcinoma: Assessment of tumor-related vascularization. Eur J Radiol, 2010; 73 (1): 148-152.

  5. Matarrese M, Bedeschi P, Scardaoni R, Sudati F, Savi A, Pepe A, Masiello V, Todde S, Gianolli L, Messa C, Fazio F. Automated production of copper radioisotopes and preparation of high specific activity [64Cu]Cu-ATSM for PET studies. Appl Radiat Isot, 2010; 68 (1): 5-13.

 

Anno 2009

  1. Bellani G, Messa C, Guerra L, Spagnolli E, Foti G, Patroniti N, Fumagalli R, Musch G, Fazio F, Pesenti A. Lungs with acute respiratory distress syndrome show diffuse inflammation in normally aerated regions: A [18F]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography study*. Crit Care Med, 2009; 37 (7): 2216-2222.

  2. Belloli S, Jachetti E, Moresco RM, Picchio M, Lecchi M, Valtorta S, Freschi M, Hess Michelini R, Bellone M and F. Fazio. Characterization of preclinical models of prostate cancer using PET based molecular imaging. Eur J Nucl Med Mol Imaging, 2009; 36 (8): 1245-1255.

  3. Briganti A, Karnes JR, Da Pozzo LF, Cozzarini C, Gallina A, Suardi N, Bianchi M, Fazio F, Rigatti P, Montorsi F, Blute ML. Two Positive Nodes Represent a Significant Cut-off Value for Cancer Specific Survival in Patients with Node Positive Prostate Cancer. A New Proposal Based on a Two-Institution Experience on 703 Consecutive N+ Patients Treated with Radical Prostatectomy, Extended Pelvic Lymph Node Dissection and Adjuvant Therapy. Eur Urol, 2009; 55(2):261-270.

  4. Crocchiolo R, Fallanca F, Giovacchini G, Ferreri AJ, Assanelli A, Verona C, Pescarollo A, Bregni M, Ponzoni M, Gianolli L, Fazio F, Ciceri F. Role of (18)FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma. Ann Hematol, 2009; 88 (12): 1229-1236.

  5. Da Pozzo LF, Cozzarini C, Briganti A, Suardi N, Salonia A, Bertini R, Gallina A, Bianchi M, Fantini GV, Bolognesi A, Fazio F, Montorsi F, Rigatti P. Long-Term Follow-up of Patients with Prostate Cancer and Nodal Metastases Treated by Pelvic Lymphadenectomy and Radical Prostatectomy: The Positive Impact of Adjuvant Radiotherapy. Eur Urol, 2009; 55 (5): 1003-1011.

  6. Di Muzio N, Fiorino C, Cozzarini C, Alongi F, Broggi S, Mangili P, Guazzoni G, Valdagni R, Calandrino R, Fazio F. Phase I-II Study of Hypofractionated Simultaneous Integrated Boost with Tomotherapy for Prostate Cancer. Int J Radiat Oncol Biol Phys, 2009; 74: 392-398.

  7. Fallanca F, Giovacchini G, Picchio M, Bettinardi V, Messa C, Fazio F. Incidental detection by [(11C]choline PET/CT of meningiomas in prostate cancer patients. Q J Nucl Med Mol Imaging, 2009; 53 (4): 417-421.

  8. Fiorino C, Alongi F, Perna L, Broggi S, Cattaneo GM, Cozzarini C, Di Muzio N, Fazio F, Calandrino R. Dose–volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys, 2009; 75 (1): 29-35.

  9. Fragasso G, Chierchia SL, Arioli F, Carandente O, Gerosa S, Carlino M, Palloshi A, Gianolli L, Calori G, Fazio F, Margonato A. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: Long-term clinical and functional prognosis. Int J Cardiol, 2009; 137(2):137-144.

  10. Giovacchini G, Fallanca F, Landoni C, Gianolli L, Picozzi P, Attuati L, Terreni M, Picchio M, Messa C, Fazio F. C-11 Choline versus F-18 Fluorodeoxyglucose for imaging meningiomas: an initial experience. Clin Nucl Med, 2009; 34 (1): 7-10

  11. Giovacchini G, Picchio M, Schipani S, Landoni C, Gianolli L, Bettinardi V, Di Muzio N, Gilardi MC, Fazio F, Messa C. Changes in glucose metabolism during and after radiotherapy in non-small cell lung cancer. Tumori, 2009; 95 (2): 177-184.

  12. Mancosu P, Sghedoni R, Bettinardi V, Fioroni F, Aquilina MA, Grassi E, Fazio F, Borasi G, Gilardi MC. 4D-PET data sorting into different number of phases: a NEMA IQ phantom study. J Appl Clin Med Phys, 2009; 10 (4): 2917.

  13. Mansueto R, Grimaldi A, Mangili G, Picchio M, Giovacchini G, Viganò R, Messa C, Fazio F. PET/CT introduction in the clinical management of patients with suspected recurrence of ovarian cancer: A cost-effectiveness analysis. Eur J Cancer Care, 2009; 18 (6): 612-619.

  14. Pastorino U, Landoni C, Marchianò A, Calabrò E, Sozzi G, Miceli R, Picchio M, Mariani L, Messa C, Fazio F. Fluorodeoxyglucose uptake measured by positron emission tomography and standardized uptake value predicts long-term survival of CT screening detected lung cancer in heavy smokers. J Thorac Oncol, 2009; 4 (11): 1352-1356.

  15. Paulesu E, Vallar G, Berlingeri M, Signorini M, Vitali P, Burani C, Perani D, Fazio F. Supercalifragilisticexpialidocious: How the brain learns words never heard before. Neuroimage, 2009; 45 (4): 1368-1377.

  16. Tettamanti M, Rotondi I, Perani D, Scotti G, Fazio F, Cappa SF, Moro A.Syntax without language: Neurobiological evidence for cross-domain syntactic computations. Cortex, 2009; 45 (7): 825-838.

  17. Visigalli I, Moresco RM, Belloli S, Politi LS, Gritti A, Ungaro D, Matarrese M, Turolla E, Falini A, Scotti G, Naldini L, Fazio F, Biffi A. Monitoring disease evolution and treatment response in lysosomal disorders by the peripheral benzodiazepine receptor ligand PK11195. Neurobiol Dis, 2009; 34 (1): 51-62.

 

Anno 2008

  1. Alongi F, Di Muzio N, Motta M, Broggi S, De Martin E, Bolognesi A, Cattaneo M, Calandrino R, Fazio F. Adenoid cystic carcinoma of trachea treated with adjuvant hypofractionated tomotherapy. Case report and literature review. Tumori, 2008; 94 (1): 121-125.

  2. Alonso Clarke R, Scifo P, Rizzo G, Dell'Acqua F, Scotti G, Fazio F. Noise correction on rician distributed data for fibre orientation estimators. IEEE Trans Med Imaging, 2008; 27: 1242-1251.

  3. Broggi S, Mauro Cattaneo G, Molinelli S, Maggiulli E, Del Vecchio A, Longobardi B, Perna L, Fazio F, Calandrino R. Results of a two-year quality control program for a helical tomotherapy unit. Radiother Oncol, 2008; 86 (2): 231-241.

  4. Cappelli A, Mancini A, Sudati F, Valenti S, Anzini M, Belloli S, Moresco RM, Matarrese M, Vaghi M, Fabro A, Fazio F, Vomero S. Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium. Bioconjug Chem, 2008; 19 (6): 1143-1153.

  5. Cattaneo GM, Dell'oca I, Broggi S, Fiorino C, Perna L, Pasetti M, Sangalli G, di Muzio N, Fazio F, Calandrino R. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. Radiother Oncol, 2008; 88 (3): 310-318.

  6. Cozzarini C, Fiorino C, Di Muzio N, Valdagni R, Salonia A, Alongi F, Broggi S, Guazzoni G, Montorsi F, Rigatti P, Calandrino R, Fazio F. Hypofractionated adjuvant radiotherapy with helical Tomotherapy after radical prostatectomy: Planning data and toxicity results of a Phase I-II study. Radiother Oncol, 2008; 88 (1): 26-33.

  7. Crocchiolo R, Canevari C, Assanelli A, Lunghi F, Tassara M, Stanghellini ML, Clerici D, Landoni C, Servida P, Bernardi M, Peccatori J, Ferreri A, Gianolli L, Bordignon C, Caligaris-Cappio F, Ciceri F, Fazio F. Pre-transplant 18FDG-PET predicts outcome in lymphoma patients treated with high-dose sequential chemotherapy followed by autologous stem cell transplantation. Leuk Lymphoma; 2008; 49 (4): 727-733.

  8. Fallanca F, Giovacchini G, Ponzoni M, Gianolli L, Ciceri F, Fazio F. Cervical thymic hyperplasia after chemotherapy in an adult patient with Hodgkin lymphoma: a potential cause of false-positivity on [(18)F]FDG PET/CT scanning. Br J Haematol, 2008; 140 (5): 477.

  9. Fiorino C, Alongi F, Broggi S, Mauro Cattaneo G, Cozzarini C, Di Muzio N, Maggiulli E, Mangili P, Perna L, Valdagni R, Fazio F, Calandrino R. Physics aspects of prostate tomotherapy: Planning optimization and image-guidance issues. Acta Oncol, 2008; 47 (7): 1309-1316.

  10. Fiorino C, Di Muzio N, Broggi S, Cozzarini C, Maggiulli E, Alongi F, Valdagni R, Fazio F, Calandrino R. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. Int J Radiat Oncol Biol Phys, 2008; 71 (2): 611-617.

  11. Garibotto V, Borroni B, Kalbe E, Herholz K, Salmon E, Holtoff V, Sorbi S, Cappa SF, Padovani A, Fazio F, Perani D. Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology, 2008; 71 (17): 1342-1349.

  12. Giovacchini G, Gajate AM, Messa C, Fazio F. Increased C-11 choline uptake in pagetic bone in a patient with coexisting skeletal metastases from prostate cancer. Clin Nucl Med, 2008; 33 (11): 797-798.

  13. Giovacchini G, Picchio M, Coradeschi E, Scattoni V, Bettinardi V, Cozzarini C, Freschi M, Fazio F, Messa C. [(11)C]Choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy. Eur J Nucl Med Mol Imaging, 2008; 35 (6): 1065-1073.

  14. Godino C, Messa C, Gianolli L, Landoni C, Margonato A, Cera M, Stefano C, Cianflone D, Fazio F, Maseri A. Multifocal, persistent cardiac uptake of [18-F]-Fluoro-Deoxy-Glucose detected by positron emission tomography in patients with acute myocardial infarction. Circ J, 2008; 72 (11): 1821-1828.

  15. Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Alberzoni C, Leone EB, Meloni F, Valsecchi MG, Fazio F. Hepatocellular carcinoma in cirrhotic liver disease functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol, 2008; 15 (7): 919-927.

  16. Ippolito D, Sironi S, Pozzi M, Antolini L, Ratti L, Meloni F, Invernizzi F, Valsecchi MG, Fazio F. Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations. J Comput Assist Tomogr, 2008; 32 (6): 855-858.

  17. Iori M, Cattaneo GM, Cagni E, Fiorino C, Borasi G, Riccardo C, Iotti C, Fazio F, Nahum AE. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol, 2008; 88 (1): 34-45.

  18. Mancosu P, Bettinardi V, Passoni P, Gusmini S, Cappio S, Gilardi MC, Cattaneo GM, Reni M, Del Maschio A, Di Muzio N, Fazio F. Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. Radiother Oncol, 2008; 87 (3): 339-342.

  19. Moresco RM, Lavazza T, Belloli S, Lecchi M, Pezzola A, Todde S, Matarrese M, Carpinelli A, Turolla E, Zimarino V, Popoli P, Malgaroli A, Fazio F. Quinolinic acid induced neurodegeneration in the striatum: a combined in vivo and in vitro analysis of receptor changes and microglia activation. Eur J Nucl Med Mol Imaging, 2008; 35 (4): 704-715.

  20. Motta M, Alongi F, Bolognesi A, Cozzarini C, Muzio ND, Fazio F. Remission of refractory neurosarcoidosis treated with brain radiotherapy: a case report and a literature review. Neurologist, 2008; 14 (2): 120-124.

  21. Ottobrini L, Ciana P, Moresco R, Lecchi M, Belloli S, Martelli C, Todde S, Fazio F, Gambhir SS, Maggi A, Lucignani G. Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application. Eur J Nucl Med Mol I, 2008; 35 (2): 365-378.

  22. Panzacchi A, Moresco RM, Garibotto V, Antonini A, Gobbo C, Isaias IU, Goldwurm S, Bonaldi L, Carpinelli A, Pezzoli G, Fazio F, Perani D. A voxel-based PET study of dopamine transporters in Parkinson's disease: Relevance of age at onset. Neurobiol Dis, 2008; 31 (1): 102-109.

  23. Perani D, Garibotto V, Gorini A, Moresco RM, Henin M, Panzacchi A, Matarrese M, Carpinelli A, Bellodi L, Fazio F. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder. NeuroImage, 42 (1): 306-314.

  24. Picchio M, Messa C. Giglioni B, Sanvito F, Caporizzo E, Landoni C, Arrigoni G, Carretta A, Nicoletti R, Zannini P, Del Maschio A, Fazio F. Increased [11C]Choline uptake in bronchioalveolar cell carcinoma with negative [18F]FDG uptake. A PET/CT and pathology study. Current Radiopharmaceuticals, 2008; 1: 62-64.

  25. Schiavina R, Scattoni V, Castellucci P, Picchio M, Corti B, Briganti A, Franceschelli A, Sanguedolce F, Bertaccini A, Farsad M, Giovacchini G, Fanti S, Grigioni WF, Fazio F, Montorsi F, Rigatti P, Martorana G. (11)C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms. Eur Urol, 2008; 54 (2): 392-401.

  26. Widesott L, Pierelli A, Fiorino C, Dell'oca I, Broggi S, Cattaneo GM, Di Muzio N, Fazio F, Calandrino R, Schwarz M. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: Planning comparison and NTCP evaluation. Int J Radiat Oncol Biol Phys, 2008; 72 (2): 589-596.

 

Anno 2007

  1. Bettinardi V, Mancosu P, Danna M, Giovacchini G, Landoni C, Picchio M, Gilardi MC, Savi A, Castiglioni I, Lecchi M, Fazio F.Two-dimensional vs three-dimensional imaging in whole body oncologic positron emission tomography/computed tomography: a Discovery-STE phantom and patient study. Q J Nucl Med Mol Imaging, 2007; 51 (3): 214-223.

  2. Calandrino R, Del Vecchio A, Todde S, Fazio F. Measurement and control of the air contamination generated in a medical cyclotron facility for PET radiopharmaceuticals. Health Phys, 2007; 92 (5 Suppl 2): S70-S77.

  3. Castellucci P, Perrone AM, Picchio M, Ghi T, Farsad M, Nanni C, Messa C, Meriggiola MC, Pelusi G, Al-Nahhas A, Rubello D, Fazio F, Fanti S. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: Correlation with transvaginal ultrasonography, computed tomography, and histology. Nucl Med Commun, 2007; 28 (8): 589-595.

  4. Ceresoli GL, Cattaneo GM, Castellone P, Rizzo G, Landoni C, Gregorc V, Calandrino R, Villa E, Messa C, Santoro A, Fazio F. Role of Computed Tomography and 18F-Fluorodeoxyglucose Positron Emission Tomography image fusion in conformal radiotherapy of non-small cell lung cancer: a comparison with standard techniques with and without elective nodal irradiation.Tumori, 2007; 93 (1): 88-96.

  5. Cozzarini C, Fiorino C, Di Muzio N, Alongi F, Broggi S, Cattaneo M, Montorsi F, Rigatti P, Calandrino R, Fazio F. Significant reduction of acute toxicity following pelvic irradiation with Helical Tomotherapy in patients with localized prostate cancer. Radiother Oncol, 2007; 84 (2): 164-17.

  6. Dell’Acqua F, Rizzo G, Scifo P, Clarke RA, Scotti G, Cerutti S, Fazio F. Model-Based Deconvolution Approach to Solve Fiber Crossing in Diffusion-Weighted MR imaging. IEEE Trans Biomed Eng, 2007; 54 (3): 462-472.

  7. Filannino MA, Matarrese M, Turolla EA, Masiello V, Moresco RM, Todde S, Verza E, Magni F, Cattaneo A, Bachi A, Kienle MG, Fazio F. Synthesis and carbon-11 labeling of (R)- and (S)-thionisoxetine, norepinephrine reuptake inhibitors, potential radioligands for positron emission tomography. Appl Radiat Isot 2007; 65 (11): 1232-1239.

  8. Fiorino C, Dell'Oca I, Pierelli A, Broggi S, Cattaneo GM, Chiara A, De Martin E, Di Muzio N, Fazio F, Calandrino R. Simultaneous Integrated Boost (SIB) for nasopharynx cancer with helical tomotherapy: a planning study. Strahlenther Onkol, 2007; 183 (9): 497-505.

  9. Mangili G, Picchio M, Sironi S, Vigano R, Rabaiotti E, Bornaghi D, Bettinardi V, Crivellaro C, Messa C, Fazio F. Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer. Eur J Nucl Med Mol Imaging, 2007; 34 (5): 658-666.

  10. Mansueto M, Grimaldi A, Torbica A, Pepe G, Giovacchini G, Messa C, Fazio F. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose positron emission tomography and computed tomography comparison. Q J Nucl Med Mol Imaging; 2007; 51 (3): 224-234.

  11. Moresco RM, Pietra L, Henin M, Panzacchi A, Locatelli M, Bonaldi L, Carpinelli A, Gobbo C, Bellodi L, Perani D, Fazio F. Fluvoxamine treatment and D2 receptors: a PET study on OCD drug naïve patients. Neuropsychopharmacology, 2007; 32 (1): 197-205.

  12. Moresco RM, Perani D, Garibotto V, Moresco RM, Ortelli P, Corbo M, Fazio F, Folli F. PET evidence of central GABAergic changes in stiff-person syndrome. Mov Disord, 2007; 22 (7): 1030-1033.

  13. Rizzo G, Castiglioni I, Russo G, Tana MG, Dell’Acqua F, Gilardi MC, Fazio F. Using deconvolution to improve PET spatial resolution in OSEM iterative reconstruction. Method Inform Med, 2007; 46: 231-235.

  14. Roscigno M, Cozzarini C, Scattoni V, Bertini R, Da Pozzo L, Pasta A, Montorsi F, Bolognesi A, Fiorino C, Colombo R, Fazio F, Rigatti P. A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy. Radiother Oncol, 2007; 82 (1): 30-37.

  15. Scattoni V, Picchio M, Suardi N, Messa C, Freschi M, Roscigno M, Da Pozzo L, Bocciardi A, Rigatti P, Fazio F. Detection of lymph-node metastases with integrated [(11)C]Choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol, 2007; 52 (2): 423-429.

  16. Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V, Perego P, Mangioni C, Messa C, Fazio F. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in detection of pelvic recurrence. Eur J Nucl Med Mol I, 2007; 34 (4): 472-479.

  17. Spagnolo P, Sironi S, Khouri T, Garlaschi G, Fazio F. Myocardial bridging of the left anterior descending coronary artery and anomalous origin of circumflex coronary artery: preoperative assessment with MDCT. AJR Am J Roentgenol; 2007; 188 (1): W17-20.

 

Anno 2006

  1. Calandrino R, Del Vecchio A, Savi A, Todde S, Griffoni V, Brambilla S, Parisi R, Simone G, Fazio F. Decommissioning procedures for an 11 MeV self-shielded medical cyclotron after 16 years of working time. Health Phys, 2006; 90 (6): 588-596.

  2. Cappelli A, Matarrese M, Moresco RM, Valenti S, Anzini M, Vomero S, Turolla EA, Belloli S, Simonelli P, Filannino MA, Lecchi M, Fazio F. Synthesis, labeling, and biological evaluation of halogenated 2 quinolinecarboxamides as potential radioligands for the visualization of peripheral benzodiazepine receptors. Bioorg Med Chem, 2006; 14 (12): 4055-4066.

  3. Carpinelli A, Magni F, Cattaneo A, Matarrese M, Turolla E, Todde S, Bosso N, Galli Kienle M, Fazio F. Improved synthesis and radiolabeling of [(11)C]MP4A, a suitable ligand for the investigation of the cholinergic system using PET. Appl Radiat Isot, 2006; 64 (2): 182-186.

  4. Cortelli P, Perani D, Montagna P, Gallassi R, Tinuper P, Federica P, Avoni P, Ferrillo F, Anchisi D, Moresco RM, Fazio F, Parchi P, Baruzzi A, Lugaresi E, Gambetti P. Pre-symptomatic diagnosis in fatal familial insomnia: serial neurophysiological and 18FDG-PET studies. Brain, 2006; 129 (Pt 3): 668-675.

  5. Danna M, Lecchi M, Bettinardi V, Gilardi MC, Stearns CW, Lucignani G and Fazio F. Generation of the acquisition-specific NEC (AS-NEC) curves to optimize the injected dose in 3D 18F-FDG whole body PET studies. IEEE Transactions on Nuclear Science, 2006; 53 (1): 86-92.

  6. Fiorino C, Dell'Oca I, Pierelli A, Broggi S, Martin ED, Muzio ND, Longobardi B, Fazio F, Calandrino R. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol, 2006; 78 (3): 276-282.

  7. Mangili G, De Marzi P, Beatrice S, Rabaiotti E, Vigano R, Frigerio L, Gentile C, Fazio F. Paclitaxel and concomitant radiotherapy in high-risk endometrial cancer patients: preliminary findings. BMC Cancer, 2006; 6 (1): 198.

  8. Messa C, Di Muzio N, Picchio M, Gilardi MC, Bettinardi V, Fazio F. PET/CT and radiotherapy. Q J Nucl Med Mol Imaging, 2006; 50 (1): 4-14.

  9. Moresco RM, Matarrese M, Fazio F. PET and SPET molecular imaging: focus on serotonin system. Curr Top Med Chem, 2006; 6 (18): 2027-2034.

  10. Perani D, Garibotto V, Hadjigeorgiou GM, Papadimitriou D, Fazio F, Papadimitriou A. Positron emission tomography changes in PARK1 mutation. Mov Disord, 2006; 21 (1): 127-130.

  11. Rizzo G, Castiglioni I, Russo G, Gilardi MC, Panzacchi A, Fazio F. Data rebinning and reconstruction in 3D PET/CT oncological studies: a Monte Carlo evaluation. IEEE Transaction on Nuclear Science, 2006; 53 (1): 139-146.

  12. Salonia A, Gallina A, Camerota TC, Picchio M, Freschi M, DaPozzo LF, Guazzoni G, Fazio F, Rigatti P, Montorsi F. Bone metastases are infrequent in patients with newly diagnosed prostate cancer: analysis of their clinical and pathologic features. Urology, 2006; 68 (2): 362-366.

  13. Sansone V, Meola G, Perani D, Fazio F, Garibotto V, Cotelli M, Vitelli E. Glucose metabolism and dopamine PET correlates in a patient with myotonic dystrophy type 2 and parkinsonism. J Neurol Neurosurg Psychiatry, 2006; 77 (3): 425-426.

  14. Sironi S, Buda A, Picchio M, Perego P, Galimberti S, Moreni R, Pellegrino A, Colombo M, Mangioni C, Messa C, Fazio F. lymph node metastasis in patients with clinical early stage cervical cancer: Detection with integrated FDG PET/CT. Radiology, 2006;238 (1): 272-279.

  15. Zerbini G, Bonfanti R, Meschi F, Bognetti E, Paesano PL, Gianolli L, Querques M, Maestroni A, Calori G, Del Maschio A, Fazio F, Luzi L, Chiumello G. Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes. Diabetes, 2006; 55 (9): 2620-2625.

     

Anno 2005

  1. Anchisi D, Borroni B, Franceschi M, Kerrouche N, Kalbe E, Beuthien-Beumann B, Cappa S, Lenz O, Ludecke S, Marconi A, Mielke R, Ortelli P, Padovani A, Pelati O, Pupi A, Scarpini E, Weisenbach S, Herholz K, Salmon E, Holthoff V, Sorbi S, Fazio F, Perani D. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol. 2005; 62 (11): 1728-1733.

  2. Bottini G, Paulesu E, Gandola M, Loffredo S, Scarpa P, Sterzi R, Santilli I, Defanti CA, Scialfa G, Fazio F, Vallar G. Left caloric vestibular stimulation ameliorates right hemianesthesia. Neurology, 2005; 65 (8): 1278-1283.

  3. Canessa N, Gorini A, Cappa SF, Piattelli-Palmarini M, Danna M, Fazio F, and Perani D. The effect of social content on deductive reasoning: a fMRI study. Hum Brain Mapp, 2005; 26 (1): 30-43.

  4. Castiglioni I, Buvat I, Rizzo G, Gilardi MC, Feuardent J, Fazio F. An open-to-public Monte Carlo database for validation purpose in Emission Tomography. Eur J Nucl Med Mol Imaging, 2005; 32 (10): 1234-1239.

  5. Castiglioni I, Rizzo G, Gilardi MC, Bettinardi V, Savi A, Fazio F. Lesion detectability and quantification in PET/CT oncological studies by Monte Carlo simulations. IEEE Trans Nucl Sci, 2005; 52 (1): 136-142.

  6. Colabufo NA, Berardi F, Contino M, Fazio F, Matarrese M, Moresco RM, Niso M, Perrone R, Tortorella V. Distribution of sigma receptors in EMT-6 cells: preliminary biological evaluation of PB167 and potential for in-vivo PET. J Pharm Pharmacol. 2005; 57 (11): 1453-1459.

  7. Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, Socci C, Folli F, Fazio F, Astorri E, Del Maschio A, Secchi A. Related Articles, Links Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care; 2005;28 (6): 1358-1365.

  8. Franceschi M, Anchisi D, Pelati O, Zuffi M, Matarrese M, Moresco RM, Fazio F, Perani D. Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration. Ann Neurol, 2005; 57(2): 216-225.

  9. Messa C, Ceresoli GL, Rizzo G, Artioli D, Cattaneo M, Castellone P, Gregorc V, Picchio M, Landoni C, Fazio F. Feasibility of [18F]FDG-PET and co-registered CT on clinical target volume definition of advanced non-small cell lung cancer. Q J Nucl Med, 2005; 49: 259-266.

  10. Moresco RM, Fazio F. SPET in psychopharmacolgy. Q J Nucl Med Mol Imaging, 2005; 49 (2): 205-214.

  11. Moresco RM, Fazio F. Molecular imaging of individual behaviour. Eur J Nucl Med Mol Imaging, 2005; 32: 717-719.

  12. Moresco RM, Todde S, Belloli S, Simonelli P, Panzacchi A, Rigamonti M, Galli-Kienle M and Fazio F. In vivo imaging of adenosine A2a receptors in rat and primate brain using [11C]SCH442416. Eur J Nucl Med Mol I, 2005; 32 (4): 405-413.

  13. Pepe G, Rossetti C, Sironi S, Landoni C, Gianolli L, Pastorino U, Zannini P, Mezzetti M, Grimaldi A, Galli L, Messa C, Fazio F. Patients with known or suspected lung cancer: evaluation of clinical management changes due to 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET) study. Nucl Med Commun, 2005; 26 (9): 831-837.

  14. Picozzi P, Rizzo G, Landoni C, Attuati L, Franzin A, Messa C, Ferrari da Passano C, Bettinardi V and Fazio F. A simplified method to integrate metabolic images in stereotactic procedures using a PET/CT scanner. Stereotactic and Functional Neurosurgery, 2005; 83 (5-6): 208-212.

  15. Rigamonti MM, Spiezio C, Poli MD, Fazio F. Laterality of manual function in foraging and positional behavior in wild indri (Indri indri). Am J Primatol, 2005; 65 (1): 27-38.

  16. Rizzo G, Castiglioni I, Arienti R, Cattaneo GM, Landoni C, Artioli D, Gilardi MC, Messa C, Reni M, Ceresoli GE, Fazio F. Automatic registration of PET and CT studies for clinical use in thoracic and abdominal conformal radiotherapy. Q J Nucl Med, 2005; 49: 267-279.

  17. Silani G, Frith U, Demonet JF, Fazio F, Perani D, Price C, Frith CD, Paulesu E. Brain abnormalities underlying altered activation in dyslexia: a voxel based morphometry study. Brain, 2005; 128: 2453-2461.

  18. Sironi S, Messa C, Fazio F. Role of integrated 18-F FDG PET/CT in recurrent ovarian cancer. Current Medical Imaging Reviews, 2005; 1: 1-4.

  19. Tettamanti M, Buccino G, Saccuman MC, Gallese V, Danna M, Scifo P, Fazio F, Rizzolatti G, Cappa SF, Perani D. Listening to action-related sentences activates fronto-parietal motor circuits. J Cognitive Neurosci, 2005; 17 (2): 1-9.

  20. Tettamanti M, Moro A, Messa C, Moresco RM, Rizzo G, Carpinelli A, Matarrese M, Fazio F, Perani D. Basal ganglia and language: phonology modulates dopaminergic release. Neuroreport, 2005; 16: 397-401.

  21. Turolla EA, Matarrese M, Belloli S, Moresco RM, Simonelli P, Todde S, Fazio F, Magni F, Galli Kienle M, Leopoldo M, Berardi F, Colabufo NA, Lacivita E, Perrone R. 11C-Labelling of N-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl]arylcarboxamide derivatives and evaluation as potential radioligands for PET imaging of dopamine D3 receptors. J Med Chem, 2005; 48 (22): 7018-7023.

  22. Villa AM, Caporizzo E, Papagni A, Miozzo L, Buttero PD, Grilli MD, Amboldi N, Fazio F, Doglia SM, Giglioni B. Choline and phosphatidylcholine fluorescent derivatives localization in carcinoma cells studied by laser scanning confocal fluorescence microscopy. Eur J Cancer, 2005; 41 (10): 1453-1459.

  23. Vitali P, Abutalebi J, Tettamanti M, Rowe J, Scifo P, Fazio F, Cappa SF, Perani D. Generating animal and tool names: an fMRI study of effective connectivity. Brain Lang, 2005; 93 (1): 32-45.

 

Anno 2004

  1. Alberici A, Gobbo C, Panzacchi A, Nicosia F, Ghidoni R, Benussi L, Hock C, Papassotiropoulos A, Liberini P, Growdon JH, Frisoni GB, Villa A, Zanetti O, Cappa S, Fazio F, Binetti G. Frontotemporal dementia: impact of P301L tau mutation on a healthy carrier. J Neurol Neurosurg Psychiatry, 2004; 75:1607-1610.

  2. Belloli S, Moresco RM, Matarrese M, Biella G, Sanvito F, Simonelli P, Turolla E, Olivieri S, Cappelli A, Vomero S, Galli-Kienle M and Fazio F. Evaluation of three quinoline-carboxamide derivatives as potential radioligands for the in vivo pet imaging of neurodegeneration. Neurochem Int, 2004; 44 (6): 433-440.

  3. Bettinardi V, Danna M, Savi A, Lecchi M, Castiglioni I, Gilardi MC, Bammer H, Lucignani G, Fazio F. Performance evaluation of the new whole-body PET/CT scanner: Discovery ST. Eur J Nucl Med Mol I, 2004; 31: 867-881.

  4. Brambati SM, Termine C, Ruffino M, Stella G, Fazio F, Cappa SF, Perani D. Regional reductions of gray matter volume in familial dyslexia. Neurology, 2004, 63: 742-745.

  5. Brasca LE, Zanello A, De Gasperi A, De Cobelli F, Zerbi A, Fazio F, Del Maschio A. Intrapancreatic accessory spleen mimicking a neuroendocrine tumor: Magnetic resonance findings and possible diagnostic role od different nuclear medicine tests. Eur Radiol, 2004; 14 (7): 1322-1323.

  6. Cappelli A, Giuliani G, Pericot Mohr G, Gallelli A, Anzini M, Vomero S, Cupello A, Scarrone S, Matarrese M, Moresco RM, Fazio F, Finetti F, Morbidelli L, Ziche M. A nonpeptide NK1 receptor agonist showing subpicomolar affinity. J Med Chem, 2004; 47 (6): 1315-1318.

  7. Carlesimo GA, Turriziani P, Paulesu E, Gorini A, Caltagirone C, Fazio F, Perani D. Brain activity during intra- and cross-modal priming: new empirical data and review of the literature. Neuropsychologia, 2004; 42: 14-24.

  8. Fazio F, Picchio M, Messa C. Is (11)C-choline the most appropriate tracer for prostate cancer? Eur J Nucl Med Mol Imaging, 2004; 31 (5): 753-755.

  9. Gugiatti A, Grimaldi A, Rossetti C, De Marchis D, Borgonovi E, Fazio F. Economic analyses on the useof positron emission tomography for the work-up of solitary pulmonary nodules and for staging patients with non-small-cell-lung-cancer in Italy. Q J Nucl Med, 2004; 48 (1): 49-61.

  10. Lanzetta M, Perani D, Anchisi D, Rosen B, Danna M, Scifo P, Fazio F, Lundborg G. Early use of artificial sensibility in hand transplantation. Scand J Plast Reconstr Surg Hand Surg, 2004; 38 (2): 106-111.

  11. Lucignani G, Panzacchi A, Bosio L, Moresco RM, Ravasi L, Carpinelli A, Coppa I, Chiumello G, Frey K, Koeppe R, Fazio F. GABAA receptor abnormalities in prader-willi syndrome assessed with positron emission tomography and [11C]flumazenil. Neuroimage, 2004; 22 (1): 22-28.

  12. Matarrese M, Salimbeni A, Turolla EA, Turozzi D, Moresco RM, Poma D, Magni F, Todde S, Rossetti C, Sciarrone MT, Bianchi G, Kienle MG, Fazio F. 11C-Radiosynthesis and preliminary human evaluation of the disposition of the ACE inhibitor [11C]zofenoprilat. Bioorg Med Chem, 2004; 12: 603-611.

  13. Messa C, Bettinardi V, Picchio M, Pelosi E, Landoni C, Gianolli L, GilardI MC, Fazio F. PET/CT in diagnostic oncology. Q J Nucl Med,2004; 48 (2): 66-75.

  14. Monti LD, Landoni C, Setola E, Galluccio E, Lucotti P, Sandoli EP, Origgi A, Lucignani G, Piatti P, Fazio F. Myocardial insulin resistance associated with chronic hypertriglycediremia and increased FFA leveld in type 2 diabetic patients. Am J Physiol Heart Circ Physiol, 2004; 287 (3): H1225-231.

  15. Moresco RM, Cavallaro R, Messa C, Bravi D, Gobbo C, Galli L, Lucignani G, Colombo C, Rizzo G, Velonà I, Smeraldi E, Fazio F. Cerebral D2 and 5HT2 receptor occupancy in schizophrenic patients treated with olanzapine or clozapine. J Psychopharmacol, 2004;18 (3): 355-365.

  16. Pelosi E, Messa C, Sironi S, Picchio M, Landoni C, Bettinardi V, Gianolli L, Del Maschio A, Gilardi MC, Fazio F. Value of integrated PET/CT for lesion localization in cancer patients: a comparative study. Eur J Nucl Med Mol I, 2004; 31 (7): 932-939.

  17. Rizzo G, Cattaneo GM, Castellone P, Castiglioni I, Ceresoli GL, Messa C, Landoni C, Gilardi MC, Arienti R, Cerutti S, Fazio F. Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment. Annals of Biomedical Engineering, 2004; 32 (10): 1399-1408.

  18. Scattoni V, Montorsi F, Picchio M, Fazio F, Roscigno M, Salonia A, Rigatti P. Techniques for detection recurrent prostate cancer after radical prostaectomy. Am J Urology Review, 2004; 2: 555-564.

  19. Scattoni V, Montorsi F, Picchio M, Roscigno M, Salonia A, Rigatti P, FazioF. Diagnosis of local recurrence after radial prostatectomy. BJU Int, 2004; 93: 680-685.

  20. Sironi S, Messa C, Cistaro A, Landoni C, Provenzi M, Giraldi E, Sonzogni A, Fazio F. Recurrent hepatoblastoma in orthotopic transplanted liver: detection with FDG Positron Emission Tomography. Am J Roentgenol, 2004; 182 (5): 1214-1216.

  21. Sironi S, Messa C, Mangili G, Zangheri B, Aletti G, Garavaglia E, Vigano R, Picchio M, Taccagni G, Maschio AD, Fazio F. Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings. Radiology, 2004; 233 (2): 433-440.

  22. Zangheri B, Messa C, Picchio M, Gianolli L, Landoni C, Fazio F. PET/CT and breast cancer. Eur J Nucl Med Mol I, 2004; 31 (Suppl. 1): S135-S142.

 

Anno 2003

  1. Bettinardi V, Alenius S, Numminen P, Teras M, Gilardi MC, Fazio F. Routsalainen U. Implementation and evaluation of an ordered subsets reconstruction algorithm for transmission PET studies using median root prior and inter-uptade median filtering. Eur J Nucl Med Mol Imaging, 2003; 30: 222-231.

  2. Bettinardi V, Gilardi MC, Lecchi N, Savi A, Castiglioni I, Rizzo G, Fazio F. Integrated CT/PET systems. Nuclear Physics B (proc. Suppl), 2003; 125: 139-144.

  3. Deblieck C, Pesenti G, Scifo P, Fazio F, Bricolo E, Russo GL, Scialfa G, Cossu M, Bottini G, Paulesu E. Preserved functional competence of perilesional areas in drug-resistant epilepsy with lesion in supplementary motor cortex: fMRI and neuropsychological observations. NeuroImage, 2003; 20 (4): 2225-2234.

  4. Matarrese M, Soloviev D, Todde S, Neutro F, Petta P, Carpinelli A, Brüssermann M, Galli Kienle M, Fazio F. Preparation of [11C]radioligands with high specific radioactivity on a commercial PET tracer synthesizer. Nucl Med Biol, 2003; 30: 79-83.

  5. Meola G, Sansone V, Perani D, Scarone S, Cappa S, Dragoni C, Cattaneo E, Cotelli M, Gobbo C, Fazio F, Siciliano G, Mancuso M, Vitelli E, Zhang S, Krahe R, Moxley RT. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord; 2003; 13 (10): 813-821.

  6. Messa C, Colombo C, Moresco RM, Gobbo C, Galli L, Lucignani G, Gilardi MC, Rizzo G, Smeraldi E, Zanardi R, Artigas F, Fazio F. 5-HT(2) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: A PET study. Psychopharmacology, 2003; 167: 72-78.

  7. Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli P, Deho F, De Vito ML, Heaton J, Rigatti P, Fazio. Brain activation patterns during video sexual stimulation following the administration of apomorphine: Results of a placebo-controlled study. Eur Urol, 2003; 43: 405-411.

  8. Montorsi F, Perani D, Anchisi D, Salonia A, Scifo P, Rigiroli P, Zanoni M, Heaton JPW, Rigatti P, Fazio F. Apomorphine-indiced brain modulation during sexual stimulation: A new look at central phenomena related to erectile dysfunction. Int J Impot Res, 2003; 15: 203-209.

  9. Pastorino U, Bellomi M, Landoni C, De Fiori E, Arnaldi P, Picchio M, Pelosi G, Boyle P. Fazio F. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-years results. Lancet, 2003; 362: 593-597.

  10. Pastorino U, Veronesi G, Landoni C, Leon M, Picchio M, Solli PG, Leo F, Spaggiari L, Pelosi G, Bellomi M, Fazio F. Fluorodeoxyglucose positron emission tomography improves preoperative staging of resectable lung metastasis. J Thorac Cardiovasc Surg, 2003; 126 (6): 1906-1910.

  11. Perani D, Abutalebi J, Paulesu E, Brambati S, Scifo P, Cappa SF, Fazio F. The role of age of acquisition and language usage in early, high-proficient bilinguals: Am fMRI study during verbal fluency. Hum Brain Mapp, 2003; 19: 170-182.

  12. Perani D, Cappa SF, Tettamanti M, Rosa M, Scifo P, Miozzo A, Basso A, Fazio F. A fMRI study of word retrieval in aphasia. Brain Lang, 2003; 85 (3): 357-368.

  13. Picchio M, Messa C, Landoni C, Gianolli L, Sironi S, Brioschi M, Matarrese M, Matei DV, De Cobelli F, Del Maschio A, Rocco F, Rigatti P, Fazio F. Value of [11C]choline PET in re-staging prostate cancer: A comparison with [18F]FDG-PET. J Urology, 2003; 169 (4): 1337-1340.

  14. Picchio M, Savi A, Lecchi M, Landoni C, Gianolli L, Brioschi M, Rossetti C, Gilardi MC, Fazio F. Evaluation of the clinical performances of a large Nal(TI) crystal 3D PET scanner. Q J Nucl Med, 2003; 47: 90-100.

  15. Picchio M, Sironi S, Messa C, Mangili G, Landoni C, Gianolli L, Zangheri B, Viganò R, Aletti G, De Marzi P, De Cobelli F, Del Maschio A, Ferrari A, Fazio F. Advance ovarian carcinoma: Usefulness of [18F]FDG-PET in combination with CT for lesion detection after primary treatment. Q J Nucl Med, 2003; 47: 77-84.

  16. Salmon E, Garraux G, Delbeuck X, Collette F, Kalbe E, Zuendorf G, Perani D, Fazio F, Herholz K. Predominant ventromedial frontopolar metabolic impariment in frontotemporal dementia. Neuroimage, 2003; 20 (1): 435-440.

  17. Scarrone S, Cappelli A, Cupello A, Matarrese M, Moresco RM, Fazio F. Ethanol inhibits the binding of substance P to rat brain cortex NK 1 receptors. Neurochem Res, 2003; 28: 1159-1162.

  18. Sironi S, Picchio M, Mangili G, Garavaglia E, Zangheri B, Messa C, Voci C, Taccagni GL, Del Maschio A, Fazio F. [18F]fluorodeoxyglucose positron emission tomography as a useful indicator of metastatic gestational trophoblastic tumor: preliminary results in three patients. Gynecol Oncol, 2003; 91 (1): 226-230.

  19. Wartenburger I, Heekeren HR, Abutalebi J, Cappa SF, Villringer A, Perani D. Early setting of grammatical processing in the bilingual brain. Neuron, 2003; 37: 159-170.

 

Anno 2002

  1. Antonini A, Moresco RM, Gobbo C, De Notaris R, Panzacchi A, Barone P, Bonifati V, Pezzoli G, Fazio F. Striatal dopaminergic denervation in early and late onset Parkinson’s disease assessed by PET and the tracer [(11)C]FECIT: Preliminary findings in one patient with autosomal recessive parkinsonism (Park2) Neurol Sci, 2002; 23: 51-52.

  2. Bettinardi V, Pagani E, Gilardi MC, Alenius S, Thielemans K, Teras M, Fazio F. Implementation and evaluation of a 3D One Step Late reconstruction algorithm for 3D Positron Emission Tomography brain studies using Median Root Prior. Eur J Nucl Med Mol Imaging, 2002; 29: 7-18.

  3. Castiglioni I, Cremonesi O, Giardi MC, Savi A, Bettinardi V, Rizzo G, Bellotti E, Fazio F. A Monte Carlo model of noise components in 3D PET. IEEE Trans Nucl Sci, 2002; 49 (5): 2297-2303.

  4. Fragasso G, Chierchia SL, Dosio F, Rossetti C, Gianolli L, Picchio M, Margonato A, Fazio F. High prevalence of [99m]Tc-tetrofosmin reverse perfusion pattern in patients with myocardial infarction and angiographically smooth coronary arteries. Int J Cardiac Imag, 2002; 18: 31-40.

  5. Herholz K, Salmon E, Perani D, Baron JC, Halthoff V, Frolich L, Schonknecht P, Ito K, Mielke R, Kalbe E, Zundor G, Deulbeuck X, Pelati O, Anchisi D, Fazio F, Kerrouche N, Calautti C, Beuthien-Baumann B, Menzel C, Schroder J, Kato T, Arahata Y, Henze M, Heiss DW. Discrimination between Alzheimer dementia and controls by aytomated analysis of multicenter FDG PET. NeuroImage, 2002; 17: 302-316.

  6. Lucignani G, Gobbo C, Moresco RM, Antonini A, Panzacchi A, Bonaldi L, Carpinelli A, Caraceni T, Fazio F. The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-ß-carbomethoxy-3-ß-(4-fluorophenyl)-tropane in patients with movement disorders. Nucl Med Commun, 2002; 23: 1047-1055.

  7. Matarrese M, Sudati F, Soloviev D, Todde S, Turolla EA, Galli Kienle M, Fazio F. Automation of [11C]acyl chloride synthesis using commercially available 11C-modules. Appl Radiat Isotopes, 2002; 57 (5): 675-679.

  8. Matarrese M, Moresco RM, Romeo G, Turolla EA, Simonelli P, Todde S, Belloli S, Carpinelli A, Magni F, Russo F, Galli Kienle M, Fazio F. [11C]RN5: A new agent for the in vivo imaging of myocardial alpha1-adrenoceptors. Eur J Pharmacol, 2002; 453: 231-238.

  9. Moresco RM, Dieci M, Vita A, Messa C, Gobbo C, Galli L, Rizzo G, Panzacchi A, De Peri L, Invernizzi G, Fazio F. In vivo serotonin 5HT2A receptor binding and personalità traits in healthy subjects: a PET study. NeuroImage, 2002;17 (3): 1470-1478.

  10. Moresco RM, Volonte MA, Messa C, Gobbo C, Galli L, Carpinelli A, Rizzo G, Panzacchi A, Franceschi M, Fazio F. New perspective on neurochemical effects of amantadine in the brain of parkinsonian patients: [11C]raclopride study. J Neural Transm, 2002; 109: 1265-1274.

  11. Picchio M, Landoni C, Messa C, Gianolli L, Matarrese M, De Cobelli F, Del Maschio A, Fazio F. Positive [11C]Choline and negative [18]FDG white Poistron Emissione Tomography in recurrence of prostate. Case report. Am J Roentgenol, 2002; 179 (2): 482-484.

  12. Redaelli A, Rizzo G, Arrigoni S, Di Martino E, Origgi D, Fazio F, Montevecchi F. An assisted automated procedure for vessel geometry reconstruction and hemodynamic simulations from clinical imaging. Comput Med Imag Grap, 2002; 26: 143-152.

  13. Riddell C, Buvat I, Savi A, Gilardi MC, Fazio F. Iterative reconstruction of SPECT data with adaptive regulkarization. IEEE T Nucl Sci, 2002; 49 (5): 2350-2354.

  14. Tettamanti M, Paulesu E, Scifo P, Maravita A, Fazio FR, Perani D, Marzi CA. Interhemispheric transmission of visuomotor informationin humans: fMRI evidence. J Neurophysiol, 2002; 88:1051-1058.

  15. Veronesi G, Landoni C, Pelosi G, Picchio M, Sonzogni A, Leon ME, Solli PG, Leo F, Spaggiari L, Bellomi M, Fazio F, Pastorino U. Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases. Brit J Cancer, 2002; 86: 1391-1395.